SCHEMBL540859

SCHEMBL540859

C=CCOc1ccc(C=C(C(=O)OCC)C(=O)OCC)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.64
MEN1 O00255 7/20 0.60
KMT2A Q03164 7/20 0.60
MAPT P10636 8/20 0.60
LMNA P02545 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
S1PR4 O95977 1/20 0.60
S1PR1 P21453 1/20 0.60
MAPK1 P28482 1/20 0.60
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 4/20 0.50
HSP90AA1 P07900 2/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 4/20 0.48
MITF O75030 1/20 0.48
HTT P42858 1/20 0.48
NPC1 O15118 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11100803 0.86 NR1H4 (0.72) NR1H4MEN1KMT2AMAPTLMNA
SCHEMBL6276239 0.86 NR1H4 (0.61) NR1H4MEN1KMT2AMAPTLMNA
SCHEMBL2921932 0.86 NR1H4 (0.64) NR1H4MEN1KMT2AMAPTLMNA
SCHEMBL8019734 0.85 NPC1 (0.47) NR1H4MAPTKDM4EALDH1A1HPGD
SCHEMBL12869943 0.85 NR1H4 (0.70) NR1H4MEN1KMT2AMAPTLMNA
SCHEMBL10071264 0.84 NR1H4 (0.62) NR1H4MEN1KMT2AMAPTLMNA
SCHEMBL1147726 0.83 NR1H4 (0.61) NR1H4MEN1KMT2AMAPTLMNA
SCHEMBL8412410 0.83 ALDH1A1 (0.62) MEN1KMT2AMAPTLMNAMAPK1
SCHEMBL8412412 0.83 ALDH1A1 (0.62) MEN1KMT2AMAPTLMNAMAPK1
SCHEMBL1068265 0.83 MEN1 (0.85) NR1H4MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7311897-B2 Triazines which are symmetrically substituted by phenyl, biphenyl, triphenyl or naphthyl can be used as highly effective UV absorbers for cosmetic applications CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-12-25 US claimed
US-20040191191-A1 Symmetrical triazine derivatives CIBA SPECIALTY CHEMICALS CORP. 2004-09-30 US claimed
US-8765967-B2 Microcapsules with UV filter activity and process for producing them DSM IP ASSETS B.V. (NE) 2014-07-01 US disclosed
US-8765967-B2 Microcapsules with UV filter activity and process for producing them DSM IP ASSETS B.V. (NE) 2014-07-01 US disclosed
US-8404705-B2 Naphthalene amidine imides BASF SE (DE) 2013-03-26 US disclosed
EP-1722863-B1 MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM DSM IP ASSETS BV (NL) 2012-02-08 EP disclosed
EP-2192142-B1 Novel process DSM IP ASSETS BV (NL) 2012-02-08 EP disclosed
US-8110647-B2 Process for the preparation of an organopolysiloxane functionalized with a benzalmalonate by hydrosilylation in the presence of a hydroxy carboxylic acid or a cyclic ester thereof DSM IP ASSETS B.V. (NL) 2012-02-07 US disclosed
US-20120022265-A1 MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM BERG-SCHULTZ KATJA (CH) 2012-01-26 US disclosed
US-20120022265-A1 MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM BERG-SCHULTZ KATJA (CH) 2012-01-26 US disclosed
EP-1861465-B1 CHROMOPHORE COATED METAL OXIDE PARTICLES DSM IP ASSETS BV (NL) 2010-10-13 EP disclosed
US-20090291107-A1 Chromophore Coated Metal Oxide Particles DSM IP ASSETS B.V. (NL) 2009-11-26 US disclosed
US-20080319015-A1 Insect Repellent Mixture MERCK PATENT GESELLSCHAFT (DE) 2008-12-25 US disclosed
US-7311897-B2 Triazines which are symmetrically substituted by phenyl, biphenyl, triphenyl or naphthyl can be used as highly effective UV absorbers for cosmetic applications CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-12-25 US disclosed
US-20070219275-A1 Use of Benzophenone Uv Filters for Preventing Tanning BASCHONG WERNER 2007-09-20 US disclosed
US-20070190325-A1 Microcapsules with uv filter activity and process for producing them DSM IP ASSETS B.V. (NL) 2007-08-16 US disclosed
US-20070190325-A1 Microcapsules with uv filter activity and process for producing them DSM IP ASSETS B.V. (NL) 2007-08-16 US disclosed
US-20040191191-A1 Symmetrical triazine derivatives CIBA SPECIALTY CHEMICALS CORP. 2004-09-30 US disclosed
US-6114559-A Silicone-substituted cinnamamide/malonamide/malonate compounds and photoprotective compositions comprised thereof SOCIETE L'OREAL S.A. (FR) 2000-09-05 US disclosed
US-5053290-A DIORGANOPOLYSILOXANES COMPRISING BENZALMALONATE FUNCTIONAL GROUPS RHONE-POULENC CHIMIE (FR) 1991-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291107-A1 Chromophore Coated Metal Oxide Particles PPOX, MITF, MC1R NR1H4 3499/4885MEN1 538/4885KMT2A 2271/4885
US-20070219275-A1 Use of Benzophenone Uv Filters for Preventing Tanning C1R, CBR3, AOC3 NR1H4 4458/4885MEN1 4546/4885KMT2A 3810/4885
US-20080319015-A1 Insect Repellent Mixture DDT, BCHE, DNPH1 NR1H4 1088/4885MEN1 2262/4885KMT2A 488/4885
US-20120022265-A1 MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM UACA, UROD, UMPS NR1H4 4464/4885MEN1 1079/4885KMT2A 4368/4885
US-20070190325-A1 Microcapsules with uv filter activity and process for producing them UACA, UROD, UMPS NR1H4 4464/4885MEN1 1079/4885KMT2A 4368/4885
US-20040191191-A1 Symmetrical triazine derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RNF168, CYC1 NR1H4 2170/4885MEN1 1524/4885KMT2A 2021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.